2019-nCoV CDC Probe and Primer Kit for SARS-CoV-2
We have a proven track record supporting public health crises. These kits follow CDC's Research Use Only protocol for 2019-nCoV.
learn moreWe have a proven track record supporting public health crises. These kits follow CDC's Research Use Only protocol for 2019-nCoV.
learn moreThese ValuPanel Reagents use the novel Coronavirus assay sequences designed by the US CDC. This panel contains signatures targeting the viral N gene and human RNase P gene powered by Black Hole Quencher (BHQ) probes and primers.
learn moreThe Influenza SARS-CoV-2 Multiplex ValuPanel™ Reagents are separately delivered probes and primers for RT-PCR detection of the genetic sequences of SARS-CoV-2, influenza A, and influenza B viruses.
learn moreSARS-CoV-2 Variant ValuPanel™ assays consist of separately delivered probes and primers that are designed for qualitative detection of specific SARS-CoV-2 mutations by genotyping using reverse transcription-polymerase chain reaction (RT-PCR), including Omicron. For Research Use Only. Not for use in diagnostic procedures.
learn moreYale 2019-nCoV SalivaDirect™ ValuPanel™ Reagents are now part of our ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains. These signatures target the SARS-CoV-2 virus that causes COVID-19.
learn moreThese ValuPanel Reagents use the novel Coronavirus assay sequences designed by the German Center for Infection Research (DZIF) at Charité. This panel contains signatures for RdRP and E genes powered by BlackBerry (BBQ-650) probes and primers according to the original protocol design. For Research Use Only. Not for use in diagnostic procedures.
learn moreWant to purchase BHQ Probes to detect and differentiate strains of the seasonal influenza A? LGC Biosearch currently offers InfA, InfA/H1, InfA/H3, Infa/H5a, Infa/H5b, InfB, and RNase P probes and primers for Research Use Only (RUO). Not for use in diagnostic procedures.
learn moreThe 2009 novel influenza A H1N1 virus was distinguished using BHQ probes during the pandemic. LGC Biosearch makes available InfA, swInfA, swH1 and RNase P probes and primers for Research Use Only (RUO). Not for use in diagnostic procedures.
learn moreThese ValuPanel Reagents use the novel Coronavirus assay sequences designed by the German Center for Infection Research (DZIF) at Charité. This panel contains signatures for RdRP and E genes powered by Black Hole Quencher (BHQ) probes and primers. For Research Use Only. Not for use in diagnostic procedures.
learn moreLGC Biosearch’s PDM 2009 H1N1 ValuPanel Reagents represent an improved design with enhanced sensitivity and specificity for the 2009 novel influenza A H1N1 virus. For Research Use Only (RUO). Not for use in diagnostic procedures.
learn moreLGC Biosearch offers Avian Influenza A (H7N9) ValuPanel Reagents to resolve the H7N9 virus originally found in China in the 2013 bird flu outbreak. This panel currently contains assays for InfA, H7, N9, and RNase P probes and primers. For Research Use Only (RUO). Not for use in diagnostic procedures.
learn moreValuPanel Reagents comprise sets of qPCR probes and primers to resolve the genetic signatures of different pathogen strains. As the inventor of the BHQ™ dyes, LGC Biosearch Technologies is the sole manufacturer of the true dark quencher currently used for the labeled probes in these assay designs. For Research Use Only. Not for use in diagnostic procedures.